CRISPR paper that sent stocks tumbling is retracted
A scientific paper that purported to lay bare serious flaws in the gene-editing tool known as CRISPR has been retracted by its publisher.
A scientific paper that purported to lay bare serious flaws in the gene-editing tool known as CRISPR and briefly tanked shares of genome-editing companies has been retracted by its publisher.
The , published last year
